ZACHARY K. GOLDSMITH et al. Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma. The Ophthalmology, [S. l.], p. 21–31, 2019. Disponível em: https://openventio.us/index.php/TOOJ/article/view/1235. Acesso em: 6 sep. 2026.